期刊文献+

内脏脂肪素、脂联素、瘦素与肥胖、2型糖尿病的相关性研究 被引量:7

Study on the relationship of plasma visfatin,adiponectin and leptin with obesity and type 2 diabetes mellitus
原文传递
导出
摘要 目的探讨内脏脂肪素(Visfatin)、脂联素(APN)、瘦素水平与肥胖及2型糖尿病(T2DM)的关系。方法 85例研究对象分为糖耐量正常(NGT)组和T2DM组。根据BMI,NGT组再分为正常对照(NC)组和单纯肥胖(S-Ob)组,T2DM组再分为糖尿病非肥胖(T2DM NOb)组和糖尿病肥胖(T2DMOb)组,测定并分析各组Visfatin、APN、瘦素水平并对影响因素进行相关分析。结果 (1)四组间Visfatin、APN、瘦素、FIns、HDL-C差异均有统计学意义(P<0.05或P<0.01)。(2)85例研究对象分为肥胖组及正常体重对照组,两组间Visfatin、瘦素、FIns、HDL-C、尿酸差异有统计学意义(P<0.05或P<0.01)。(3)WHR是Visfatin的独立影响因素(r=0.519,P<0.05)。结论 Visfatin可能在肥胖和T2DM的发生和发展中有一定作用。 Objective To study the relationship of visfatin, adiponectin and leptin levels with obesity and diabetes. Methods 85 cases of subjects included normal glucose tolerance (NGT) group (n =20), type 2 diabetes mellitus (T2DM) group (n=43) and simple obesity group (S-Ob,n=22). T2DM had subgroups of T2DM-Ob (n = 22) and T2DM without Ob (n = 21). Visfatin, adiponectin and leptin were determined. Results (1) Among the four groups, the differences in visfatin, adiponectin, leptin, fasting insulin and high-density lipoprotein cholesterol (HDL-C) were statistically significant(P〈0. 05, or P〈0.01). (2) The differences in visfatin, leptin, fasting insulin, HDL-C,cholesterol and uric acid(P〈0.05, or P〈0. 01)were significant between obesity and non-obesity. (3) Waist-to-hip ratio was an independent influencing factors for visfatin. (r=0. 519, P〈0. 05). Conclusion Visfatin may play a role in the occurrence and development of obesity and DM.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2010年第12期883-885,共3页 Chinese Journal of Diabetes
基金 浙江省丽水市科学技术局资助项目(2008-69)
关键词 内脏脂肪素 脂联素 瘦素 糖尿病 2型 胰岛素抵抗 肥胖 Visfatin Adiponectin Leptin Diabetes mellitus, type 2 Insulin resistance Obesity
  • 相关文献

参考文献6

  • 1Fukuhara A,Matsuda M,Nishizawa M,et al.Visfatin:a protein secreted by visceral fat that mimics the effects of insulin.Science,2005,307:426-430.
  • 2Chen MP,Chung FM,Chang DM,et al.Elevated plasma level of Visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus.J Clin Endocrinol Metab,2006,91:295-299.
  • 3Reilly MP,Iqbal N,Schutta M,et al.Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes.J Clin Endocrinal Metab,2004,89:3872-3878.
  • 4Krzyzanowska K,Krugluger W,Mittermayer F,et al.Increased visfatin concentrations in women with gestational diabetes mellitus.Clin Sci,2006,110:605-609.
  • 5Lewandowski KC,Stojanovic N,Press M,et al.Elevated serum levels of visfatin in gestational diabetes:a comparative study across various degrees of glucose tolerance.Diabetologia,2007,50:1033-1037.
  • 6马学毅.2型糖尿病伴高尿酸血症的病因与治疗新进展[J].中华老年多器官疾病杂志,2005,4(1):20-21. 被引量:29

二级参考文献6

共引文献28

同被引文献56

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部